How many institutions held KZIA - KAZIA THERAPEUTICS LTD - American Depositary Shares in Q4 2024?

No institutional holders were reported for KZIA - KAZIA THERAPEUTICS LTD - American Depositary Shares in Q4 2024; review adjacent reporting periods for trend context.

KAZIA THERAPEUTICS LTD - American Depositary Shares (KZIA)

Q: What does CUSIP 48669G105 represent in this 13F holders report?

CUSIP 48669G105 is the security identifier for KZIA - KAZIA THERAPEUTICS LTD - American Depositary Shares used to aggregate holder disclosures.

CUSIP: 48669G105

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class: Equity / American Depositary Shares
Shares outstanding: 11,337,576
Total 13F shares: 0
Share change: -2,129,596
Total reported value: $0
Number of holders: 0
Value change: -$915,427
Number of sells: 16

Quarterly Holders Quick Answers

What is CUSIP 48669G105?
CUSIP 48669G105 identifies KZIA - KAZIA THERAPEUTICS LTD - American Depositary Shares in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2025
Previous quarter: Q3 2024

Recent filing periods for CUSIP 48669G105:

Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023

KAZIA THERAPEUTICS LTD - American Depositary Shares (KZIA)

Q4 2024 13F Holders as of 31 Dec 2024

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of KZIA - KAZIA THERAPEUTICS LTD - American Depositary Shares as of Q4 2024.